Skip to content
Home/Companies/MedTech/novelex AG (forteq Nidau)
NA

novelex AG (forteq Nidau)

MedTech·Switzerland·Exited 2021·Held 1yr

novelex AG (forteq Nidau) is a MedTech company, headquartered in Switzerland.

Entry
2020
Hold
1yr
Exit
2021
Est. EV
–

Who owns novelex AG (forteq Nidau)?

novelex AG (forteq Nidau) was owned by Liberta Partners through Liberta Partners Fund II (2019 vintage) from 2020 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Liberta Partners
Investor
Liberta Partners
Liberta Partners Fund II · 2019 · Small-Mid Buyout

Key facts

HQSwitzerland
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from Liberta Partners Fund II

Other portfolio companies in the same fund.

e*Message Group
Active
TMTGermany· 2022
KKS Kemmler Kopier Systeme GmbH (NOBIX Group)
Active
Business ServicesGermany· 2022
Medas Factoring GmbH
Exited 2026
Business ServicesGermany· 2022
to
Ameropa-Reisen GmbH
Exited 2024
ConsumerGermany· 2020
to
Kienzle Automotive GmbH
Active
MobilityGermany· 2020
FMA Mechatronic Solutions AG
Active
IndustrialsLiechtenstein· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings